Skip to main content

Table 6 Multivariate Cox regression analyses of overall survival for tumor grades of T1a breast cancer patients in the matched cohort

From: Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort

Variable

T1a: GRADEI

T1a: GRADEII

T1a: GRADEIII

Multivariate Analysis

Multivariate Analysis

Multivariate Analysis

HR (95%CI)

P-value

HR (95%CI)

P-value

HR (95%CI)

P-value

SURGERY

 Breast-conserving

reference

 

reference

 

reference

 

 Total mastectomy

0.36(0.03–3.94)

0.41

2.13(0.59–7.72)

0.25

0.52(0.14–1.90)

0.32

 Modified radical mastectomy

0.54(0.03–10.37)

0.68

1.99(0.46–8.65)

0.36

0.29(0.05–1.78)

0.18

RADIATION

 No

reference

 

reference

 

reference

 

 Yes

-

-

1.78(0.52–6.12)

0.36

0.23(0.06–0.87)

0.03

CHEMOTHERAPY

 No

reference

 

reference

 

reference

 

 Yes

2.54(0.49–13.09)

0.27

1.00(0.51–1.94)

0.99

1.27(0.56–2.91)

0.57

SUBTYPE

 HoR + /HER2-

reference

 

reference

 

reference

 

 HoR + /HER2 + 

-

-

0.22(0.06–0.75)

0.02

0.10(0.01–0.79)

0.03

 HoR-/HER2 + 

1.73(0.20–15.15)

0.62

1.00(0.43–2.33)

1.00

0.68(0.22–2.15)

0.52

 HoR-/HER2-

-

-

1.13(0.44–2.93)

0.80

0.58(0.21–1.57)

0.28

AGE (year)

 < 60

reference

 

reference

 

reference

 

 ≥ 60

0.31(0.03–3.20)

0.32

3.35(1.64–6.83)

 < 0.01

2.89(1.25–6.68)

0.01

  1. Abbreviations: HR hazard ratio, HoR hormone receptor, HER2 human epidermal growth factor receptor‐2